Cargando…
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
The development of multidrug resistance (MDR) is one of the major challenges to the success of traditional chemotherapy treatment in cancer patients. Most studies to date have focused on strategies to reverse MDR following its development. However, agents utilizing this approach have proven to be of...
Autores principales: | Wang, Jinglu, Seebacher, Nicole, Shi, Huirong, Kan, Quancheng, Duan, Zhenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663620/ https://www.ncbi.nlm.nih.gov/pubmed/29137448 http://dx.doi.org/10.18632/oncotarget.19187 |
Ejemplares similares
-
Regulation of microRNAs function by circular RNAs in human cancer
por: Han, Chao, et al.
Publicado: (2017) -
Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014) -
Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991) -
Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015) -
The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)